<http://schema.org/headline>
"Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fiercebiotech.com/press-releases/merrimack-pharmaceuticals-announces-top-line-results-single-arm-phase-2-adv>